The Traderszone Network

Published in TZ Latest News 15 November, 2017 by The TZ Newswire Staff

Affimed to Present at the Jefferies 2017 London Healthcare Conference

Heidelberg, Germany, November 15, 2017 – Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, announced today that Dr. Adi Hoess, CEO, will present at the Jefferies 2017 London Healthcare Conference on Wednesday, November 15, 2017, at 4:00 pm GMT.